Two Sigma Advisers
RGLS

Two Sigma Advisers’s Regulus Therapeutics RGLS Stock Holding History

Two Sigma Advisers’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,050
Closed -$51K – 2847
2022
Q1 		$51K Buy
17,050
+1,920
+13% +$5K ﹤0.01% 2588
2021
Q4 		$48K Buy
15,130
+13,940
+1,171% +$61.9K ﹤0.01% 2477
2021
Q3 		$8K Buy
+1,190
New +$8.72K ﹤0.01% 2417
2021
Q2 		– Sell
-84,260
Closed -$1.31M – 2653
2021
Q1 		$1.31M Buy
+84,260
New +$1.25M ﹤0.01% 1497

Other funds holding RGLS

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return